Trading Options with an Edge
Select Page

Hawk’s Nest

Search by Ticker Symbol

Most Popular Articles

Welcome to Hawk’s Nest!

This page will host a collection of our equity & options research. Feel free to review the various categories and stay up to date with our most recent reports. We are also integrating a ticker search and over time this will become a great resource for company analysis as we migrate over years of our research write-ups. Content unlocks on a predetermined schedule, but if you want access to our content live to capture these opportunities I suggest taking a look at our subscription plans.

Latest Research

Intellia (NTLA) Top Name Back at Trend Support

Intellia (NTLA) shares pulled back to the 55-EMA and low-end of monthly value last week before putting in a nice hammer reversal on Friday and closing near the highs. Shares held trend support from the July lows and continue to consolidate in a bigger weekly pattern...

Unlocked Premium Content

Unusual Call Buying in Fuel Cell Play

Ballard Power (BLDP) unusual activity on 9/7 with 4000 November $16 calls active with buyers paying $2.39 to $2.50, a name with prior opening sales...

Affirm (AFRM) Earnings Preview

Affirm (AFRM) will report earnings on 9/9 after the close with the Street expecting ($0.29) EPS and $226.5M in Revenues (+60%) to close 2021 with...
More Chart SetUps

Options Flow Daily Freebies

Insider Trades

Earnings Research

Darden (DRI) Earnings Preview

Darden (DRI) reporting earnings on Thursday 9/23 before the open with the Street looking for $1.65 on $2.23B in sales. Next quarter is guided to $1.44/$2.19B while the...

Options Signal Highlights

More Trade of the Week

More Small Cap Research

Company Profile: Otis (OTIS)

Otis (OTIS) with a $20.9B market cap was recently a spin-off from United Tech (UTX) and is a leading maker and servicer of elevators and...
read more

Company Profile: Ecolab (ECL)

Description Ecolab (ECL) is a global leader in water, hygiene and energy technologies and services that protect people and vital resources.  They deliver comprehensive programs,...
read more

Company Profile: Repligen (RGEN)

Repligen (RGEN) is a $3.3B provider of advanced bioprocessing technologies used I the process of making biologic drugs.  Its customers are mainly large biopharmaceutical companies...
read more
More Company Profiles

Thematic Snapshot – Africa

Africa is one of the most intriguing investment themes for the next decade as the continent sits on the precipice of significant growth supported by...
read more
More Thematic Research